Early symptom response in patients with uncomplicated urinary tract infection treated with gepotidacin or nitrofurantoin: pooled analysis from two pivotal Phase 3 studies
- Journal:
- Clinical Infectious Diseases
- Published:
- DOI:
- 10.1093/cid/ciaf722
- Affiliations:
- 6
- Authors:
- 8
| Institutions | Authors | Share |
|---|---|---|
| GSK, United Kingdom (UK) | 0.38 | |
| GlaxoSmithKline USA, United States of America (USA) | 0.25 | |
| University of Michigan (U-M), United States of America (USA) | 0.13 | |
| Rutgers Health, United States of America (USA) | 0.13 | |
| GlaxoSmithKline Spain, Spain | 0.13 |